Form 8-K - Current report:
SEC Accession No. 0000950157-19-000879
Filing Date
2019-08-12
Accepted
2019-08-12 06:15:57
Documents
13
Period of Report
2019-08-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits
Interactive Data

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT form8k.htmiXBRL 8-K 42167
2 ex10-1.htm EX-10.1 818648
Complete submission text file 0000950157-19-000879.txt 1158293

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA akrx-20190809.xsd EX-101.SCH 4377
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE akrx-20190809_lab.xml EX-101.LAB 23692
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akrx-20190809_pre.xml EX-101.PRE 16824
6 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 4058
Mailing Address 1925 W. FIELD COURT, SUITE 300LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

IRS No.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32360 | Film No.: 191014329
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Attachments

  • Original document
  • Permalink

Disclaimer

Akorn Inc. published this content on 12 August 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 August 2019 10:35:07 UTC